Decreased placental and transcellular permeation of cefuroxime in pregnant women with diabetes

QR Code

Decreased placental and transcellular permeation of cefuroxime in pregnant women with diabetes

Background: The present study investigated the transcellular and placental permeation of cefuroxime, an antibiotic used in cesarean sections, in pregnant women with diabetes and hypertension. Methods: Fifty-three women scheduled for cesarean section were divided into three groups: healthy women (n=1...

Full description

Bibliographic Details
Main Authors:	Lalic-Popovic, M., Paunkovic, J., Grujic, Z., Golocorbin-Kon, S., Milasinovic, L., Al-Salami, Hani, Mikov, M.
Format:	Journal Article
Published:	John Wiley and Sons Inc. 2015
Online Access:	http://hdl.handle.net/20.500.11937/37305

Similar Items

Diabetes and hypertension increase the placental and transcellular permeation of the lipophilic drug diazepam in pregnant women
by: Lalic-Popovic, M., et al.
Published: (2013)

The Effect of Diabetes and Hypertension on the Placental Permeation of the Hydrophilic Drug, Ranitidine
by: Lalic-Popovic, M., et al.
Published: (2016)

Deoxycholic Acid as a Modifier of the Permeation of Gliclazide through the Blood Brain Barrier of a Rat
by: Lalic-Popovic, M., et al.
Published: (2013)

THE EFFECT OF BILE ACID SALT SODIUM 3ALPHA, 7ALPHA-DIHYDROXY-12-KETO-5BETA-CHOLANATE (MKC) AND PROBIOTIC PRETREATMENT ON GLICLAZIDE PERMEATION IN ILEAL TISSUES FROM HEALTHY AND DIABETIC RATS
by: Mikov, M., et al.
Published: (2014)

Probiotics decreased the bioavailability of the bile acid analog, monoketocholic acid, when coadministered with gliclazide, in healthy but not diabetic rats
by: Al-Salami, Hani, et al.
Published: (2012)

High-Loading Dose of Microencapsulated Gliclazide Formulation Exerted a Hypoglycaemic Effect on Type 1 Diabetic Rats and Incorporation of a Primary Deconjugated Bile Acid, Diminished the Hypoglycaemic Antidiabetic Effect
by: Golocorbin-Kon, S., et al.
Published: (2017)

Probiotic pre-treatment reduces gliclazide permeation (ex vivo) in healthy rats but increases it in diabetic rats to the level seen in untreated healthy rats
by: Al-Salami, Hani, et al.
Published: (2008)

Correlation between in vitro tests for blood brain barrier penetration with in vivo gliclazide penetration
by: Lalic-Popovic, M., et al.
Published: (2013)

Lamotrigine and valproate pharmacokinetics interactions in epileptic patients
by: Lalic, M., et al.
Published: (2009)

Diabetes development increased concentrations of the conjugated bile acid, taurocholic acid in serum, while treatment with microencapsulated-taurocholic acid exerted no hypoglycaemic effects
by: Mathavan, S., et al.
Published: (2017)

Influence of the semisynthetic bile acid MKC on the ileal permeation of gliclazide in vitro in healthy and diabetic rats treated with probiotics
by: Al-Salami, Hani, et al.
Published: (2008)

Psychosis Induced by Cefuroxime and Metronidazole
by: Othman, Zahiruddin, et al.
Published: (2014)

Gliclazide reduces MKC intestinal transport in healthy but not diabetic rats
by: Al-Salami, Hani, et al.
Published: (2009)

Placental morphology of pregnant Iraqi women with rheumatic heart disease
by: Al-Assaf, Anwar IS, et al.
Published: (2016)

Probiotics applications in autoimmune diseases
by: Al-Salami, Hani, et al.
Published: (2012)

Potential Applications of Gliclazide in Treating Type 1 Diabetes Mellitus: Formulation with Bile Acids and Probiotics
by: Mikov, M., et al.
Published: (2017)

An advanced microencapsulated system: a platform for optimized oral delivery of antidiabetic drug-bile acid formulations
by: Mooranian, A., et al.
Published: (2015)

Dried Blood Spot: Utilizing Dry Blood For Pharmacokinetic Investigations—An Old Method with Great Future for Therapeutic Drug Monitoring
by: Maksimovic, V., et al.
Published: (2017)

Development of nanoemulsion for efficient brain parental delivery of cefuroxime: designs,characterizations,and pharmacokinetics
by: Harun, Siti Norhawani, et al.
Published: (2018)

Fabrication of nanoemulsion loaded with cefuroxime for efficient translocation across the blood brain barrier
by: Harun, Siti Norhawani
Published: (2018)

Dried blood spot: Utilising dry blood for pharmacokinetic investigations - An old method with great future for therapeutic drug monitoring
by: Golocorbin-Kon, S., et al.
Published: (2018)

Maternal body weight and gestational diabetes differentially influence placental and pregnancy outcomes
by: Martino, J., et al.
Published: (2015)

Stability and Release Kinetics of an Advanced Gliclazide-Cholic Acid Formulation: The Use of Artificial-Cell Microencapsulation in Slow Release Targeted Oral Delivery of Antidiabetics
by: Mooranian, Armin, et al.
Published: (2014)

Drug Permeation across the Blood-Brain Barrier: Applications of Nanotechnology
by: Fakhoury, M., et al.
Published: (2015)

Effect of cord blood cotinine towards placental VEGF expression in pregnant second hand smoker / Muadz Baharom
by: Baharom, Muadz
Published: (2016)

Bile acids and probiotics could help treating diabetes
by: Calasan, J., et al.
Published: (2012)

Release and swelling studies of an innovative antidiabetic-bile acid microencapsulated formulation, as a novel targeted therapy for diabetes treatment
by: Mooranian, Armin, et al.
Published: (2015)

Accelerated aqueous solubility and antibacterial activity of cefuroxime axetil using microcrystalline cellulose as carrier
by: Salam, Moushumi Tabassoom, et al.
Published: (2020)

Novel chenodeoxycholic acid-sodium alginate matrix in the microencapsulation of the potential antidiabetic drug, probucol. An in vitro study
by: Mooranian, A., et al.
Published: (2015)

Pharmacological effects of nanoencapsulation of human-based dosing of probucol on ratio of secondary to primary bile acids in gut, during induction and progression of type 1 diabetes
by: Mooranian, Armin, et al.
Published: (2018)

Placental expression of the angiogenic placental growth factor is stimulated by both aldosterone and simulated starvation
by: Eisele, Nicole, et al.
Published: (2016)

Pharmacological Applications of Bile Acids and Their Derivatives in the Treatment of Metabolic Syndrome
by: Danic, M., et al.
Published: (2018)

Bile acids and their derivatives as potential modifiers of drug release and pharmacokinetic profiles
by: Pavlovic, N., et al.
Published: (2018)

The Role of Drug Metabolites in the Inhibition of Cytochrome P450 Enzymes
by: Mikov, M., et al.
Published: (2017)

Application of bile acids in drug formulation and delivery
by: Stojancevic, M., et al.
Published: (2014)

An autonomous lab on a chip for space flight calibration of gravity-induced transcellular calcium polarization in single-cell fern spores
by: Park, J.H., et al.
Published: (2017)

Eudragit®-based microcapsules of probucol with a gut-bacterial processed secondary bile acid
by: Mooranian, A., et al.
Published: (2018)

Novel nano-encapsulation of probucol in microgels: scanning electron micrograph characterizations, buoyancy profiling, and antioxidant assay analyses
by: Mooranian, A., et al.
Published: (2018)

Metabolic alterations induced by high maternal BMI and gestational diabetes in maternal, placental and neonatal outcomes
by: Martino, Jole
Published: (2013)

Release and swelling studies of an innovative antidiabetic-bile acid microencapsulated formulation, as a novel targeted therapy for diabetes treatment (vol 32, pg 151, 2014)
by: Mooranian, A., et al.
Published: (2015)

Cannot write session to /tmp/vufind_sessions/sess_o7devf4do65eln03dap2065n4r